MorphoSys News

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 29 22:23

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 26 22:13

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 26 04:36

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 25 22:40

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 24 23:08

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 24 22:08

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 23 22:19

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 22 22:36

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 19 22:19

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 19 04:33

SC 13D: Statement of acquisition of beneficial ownership by individuals-Novartis BidCo AG(11.56%),Novartis Pharma AG(11.56%), etc.

Apr 19 02:37

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 18 22:16

SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)

Apr 18 04:51

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 18 04:37

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 17 05:11

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 16 22:15

MorphoSys | SC TO-T/A: Third party tender offer statement (Amendment)

Apr 16 03:50

MorphoSys | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 12 22:57

MorphoSys | SC 14D9: Tender offer solicitation/recommendation statements filed under Rule 14d-9

Apr 11 23:59

MorphoSys | SC TO-T: Third party tender offer statement

Apr 11 18:05